GeneQuantum and InxMed have reached a technology licensing collaboration, providing strong support for innovative ADC drug research and development

/PRNewswire/ -- On July 14, 2023, GeneQuantum, a leading pioneer committed to innovative bioconjugation technology, and InxMed, a clinical-stage biotechnology...

Related Keywords

Suzhou ,Jiangsu ,China ,Beijing ,Nanjing ,Canada ,Gang Qin ,Xizang ,Shanghai ,United States ,Australia ,Zaiqi Wang ,Drug Administration ,China National Medical Products Administration ,Focal Adhesion Kinase ,Fast Track Designation ,Breakthrough Therapy Designation ,China National Medical Products ,Genequantum Healthcare ,